Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

Clinical trial NCT01014988 · COMPLETED

Trial details

NCT number: NCT01014988
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2009-11-01
Primary completion: 2015-02-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.